NIT
VNDA icon

NumerixS Investment Technologies’s Vanda Pharmaceuticals VNDA Stock Holding History

NumerixS Investment Technologies’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,186
Closed -$23K – 1308
2020
Q1 		$23K Sell
2,186
-4,011
-65% -$49.7K 0.01% 780
2019
Q4 		$102K Buy
6,197
+400
+7% +$6.05K 0.02% 669
2019
Q3 		$77K Buy
5,797
+2,598
+81% +$36.2K 0.02% 626
2019
Q2 		$45K Sell
3,199
-9,801
-75% -$156K 0.01% 791
2019
Q1 		$244K Buy
+13,000
New +$296K 0.03% 598
2018
Q4 		– Sell
-2,035
Closed -$47K – 1398
2018
Q3 		$47K Sell
2,035
-9,800
-83% -$200K 0.01% 986
2018
Q2 		$227K Buy
11,835
+5,700
+93% +$95.3K 0.05% 485
2018
Q1 		$102K Sell
6,135
-1,568
-20% -$26.2K 0.03% 650
2017
Q4 		$117K Buy
7,703
+900
+13% +$13.4K 0.03% 642
2017
Q3 		$122K Sell
6,803
-13,300
-66% -$223K 0.03% 685
2017
Q2 		$328K Sell
20,103
-20,400
-50% -$294K 0.05% 464
2017
Q1 		$567K Buy
40,503
+25,800
+175% +$368K 0.07% 368
2016
Q4 		$235K Sell
14,703
-4,997
-25% -$80.3K 0.03% 626
2016
Q3 		$328K Buy
19,700
+13,500
+218% +$182K 0.04% 518
2016
Q2 		$69K Buy
+6,200
New +$60K 0.01% 921

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

NumerixS Investment Technologies's VNDA Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Vanda Pharmaceuticals (VNDA) in Q2 2020, closing a stake of 2,186 shares — an estimated $23K sold.

NumerixS Investment Technologies first reported a position in VNDA in Q2 2016 and held it in 15 quarters. The position peaked at $567K in Q1 2017. 164 funds tracked by Wall St. Rank hold VNDA as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Vanda Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,186 Vanda Pharmaceuticals shares in Q2 2020, an estimated $23K.
  • NumerixS Investment Technologies first reported a position in Vanda Pharmaceuticals in Q2 2016 and held it in 15 quarters.
  • NumerixS Investment Technologies's Vanda Pharmaceuticals position peaked at $567K in Q1 2017.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.